Login to Your Account

Other News To Note

Friday, June 22, 2012
• Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., said it received a Nasdaq letter indicating the firm is not in compliance with the minimum bid price requirement for continued listing. Catalyst has 180 calendar days to regain compliance.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription